IND: (+91) 949418 5556
sales@envisioninteligence.com
- Home
- Industry Reports
- Healthcare
- Healthcare IT
- Europe Digital Pathology Market – Size, Outlook, Trends and Forecast (2023 – 2030)
Digital pathology is a dynamic, image-based environment that enables the acquisition, management and interpretation of pathology information generated from a digitised glass slide. Pathology is a branch of medical science that involves the study and diagnosis of disease through the examination of surgically removed organs, tissues, bodily fluids, and in some cases the whole body. Healthcare applications include teleconsultation, disease diagnosis, drug discovery, training and education.
Europe Digital Pathology Market Size & Growth:
The Europe Digital Pathology market was valued at $0.37 billion in 2019 and is estimated to reach $0.89 billion by 2025, at a CAGR of 12.5% during 2019-2025. The critical factors responsible for the growth of the Europe digital pathology are rising prevalence of cancer, increasing acceptance of digital pathology to rise lab efficiency, increasing creativities by governments and industry players, ease of consultation enabled by digital pathology. The high cost of digital pathology systems, lack of reimbursement for digital pathology enabled services, and inadequate infrastructure are hampering the growth of the Europe digital pathology market. The future scope of the market is disabling the deficiency of pathologists through digital pathology, personalised medicine, the addition of laboratory and digital pathology systems, integration of Laboratory Information Systems (LIS) and Digital Pathology Systems.
Europe Digital Pathology Market Segments Share:
The Europe digital pathology market is segmented on the type, product, application, end user and geography. By type, the Europe digital pathology market is segregated into human pathology, veterinary pathology. Human pathology is the largest market in the Europe digital pathology market owing to the factors like increasing adoption of the digital pathology to enhance lab efficiency and growing applications of digital pathology. Veterinary pathology is the promising segment tending towards the market growth. By product, the market is segregated into scanners, software, communication systems, storage systems. The software is expected to register the highest growth and is also largest market by product due to the availability of analytical, user-friendly and advanced functions for pathology diagnosis. By application, the market is categorised into teleconsultation, disease diagnosis, drug discovery, training and education. Tele-consultation is the largest market and is expected to register the fastest growth in the market owing to the increasing need for quality, and fast diagnosis have enhanced the utilisation of teleconsultation applications. By geography, the market is classified into UK, Germany, France, Italy, Spain and others.
Europe Digital Pathology Market Trends:
- Leica Biosystems and KUB Technologies, Inc. are pleased to announce a new global distribution agreement for Kubtec’s specimen imaging systems.
- The digital pathology industry just took another step forward, with the FDA clearance of a whole slide imaging system for review of digital surgical pathology slides.
Europe Digital Pathology Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have a complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried out to understand the market more comprehensively.
Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact on altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary critical players in the Europe Digital Pathology Market are:
- GE Healthcare
- Inspirata Co.
- Ventana Medical Systems, Inc.
- Leica Biosystems
- 3DHistech Ltd
- Hamamatsu Photonics, K.K.
Along with these companies, there were many other companies considered/ cited in the report while analysing the Europe Digital Pathology market. These companies hold substantial share-owning to the nature of the industry whereas the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and stable customer base.
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. The high efficiency of system, analysis and workflow
4.1.2. Application in cancer diagnosis
4.1.3. Ease in transportation and storage
4.1.4. Increasing initiatives by governments and industry players
4.2. Restraints & Challenges
4.2.1. Lack of essential infrastructure in developing countries
4.2.2. Reluctance towards the adoption of digital pathology
4.2.3. Inadequate infrastructure
4.3. Opportunities
4.3.1. Increasing application of digital pathology
4.3.2. Evolving awareness towards pertaining digital pathology
4.3.3. Addition of laboratory and digital pathology systems
4.3.4. Emerging markets to offer lucrative growth opportunities
5. Europe Digital Pathology Market– By Type
5.1. Human digital pathology
5.2. Animal digital pathology
5.3. Others
6. Europe Digital Pathology Market- By Product
6.1. Scanners
6.2. Software
6.3. Communication Systems
6.4. Storage Systems
6.5. Others
7. Europe Digital Pathology Market– By Application
7.1. Teleconsultation
7.2. Disease Diagnosis
7.3. Drug Discovery
7.4. Training and education
7.5. Others
8. Europe Digital Pathology Market-By End User
8.1. Pharmaceutical & Biotechnology Companies
8.2. Hospitals and Reference Laboratories
8.3. Academic & Research Institutes
8.4. Others
9. Europe Digital Pathology Market– By Geography
9.1. Europe
9.1.1. U.K.
9.1.2. Germany
9.1.3. France
9.1.4. Italy
9.1.5. Spain
9.1.6. Russia
9.1.7. Others
10. Europe Digital Pathology Market– Company Profiles
10.1. Leica Biosystems
10.2. Hamamatsu Photonics Inc.
10.3. Olympus Corporation
10.4. Koninklijke Philips N.V
10.5. GE Healthcare
10.6. Inspirata Co.
10.7. Ventana Medical Systems, Inc.
10.8. Leica Biosystems
10.9. 3DHistech Ltd
10.10. Hamamatsu Photonics, K.K.
10.11. Digipath Co.
10.12. Carl Zeiss AG
10.13. Olympus Corporation
10.14. Yokogawa Electronic Corporation
10.15. Quorum Technologies Inc.
11. Europe Digital Pathology Market- Competitive Landscape
11.1. Market Share Analysis
11.2. Strategies Adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
12. Market Insights
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
13. Appendix
13.1. List of tables
13.2. List of figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €2,003.71 - €6,679.04
- INR: ₹178,109.83 - ₹593,699.44
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,719.08 - £5,730.28
Description
Regional Reports
Additional information
| Report Type | Extensive Report, Miniature report, Snapshot Report |
|---|---|
| Licence | Single User License, Team License, Corporate License |
Digital pathology is a dynamic, image-based environment that enables the acquisition, management and interpretation of pathology information generated from a digitised glass slide. Pathology is a branch of medical science that involves the study and diagnosis of disease through the examination of surgically removed organs, tissues, bodily fluids, and in some cases the whole body. Healthcare applications include teleconsultation, disease diagnosis, drug discovery, training and education.
Europe Digital Pathology Market Size & Growth:
The Europe Digital Pathology market was valued at $0.37 billion in 2019 and is estimated to reach $0.89 billion by 2025, at a CAGR of 12.5% during 2019-2025. The critical factors responsible for the growth of the Europe digital pathology are rising prevalence of cancer, increasing acceptance of digital pathology to rise lab efficiency, increasing creativities by governments and industry players, ease of consultation enabled by digital pathology. The high cost of digital pathology systems, lack of reimbursement for digital pathology enabled services, and inadequate infrastructure are hampering the growth of the Europe digital pathology market. The future scope of the market is disabling the deficiency of pathologists through digital pathology, personalised medicine, the addition of laboratory and digital pathology systems, integration of Laboratory Information Systems (LIS) and Digital Pathology Systems.
Europe Digital Pathology Market Segments Share:
The Europe digital pathology market is segmented on the type, product, application, end user and geography. By type, the Europe digital pathology market is segregated into human pathology, veterinary pathology. Human pathology is the largest market in the Europe digital pathology market owing to the factors like increasing adoption of the digital pathology to enhance lab efficiency and growing applications of digital pathology. Veterinary pathology is the promising segment tending towards the market growth. By product, the market is segregated into scanners, software, communication systems, storage systems. The software is expected to register the highest growth and is also largest market by product due to the availability of analytical, user-friendly and advanced functions for pathology diagnosis. By application, the market is categorised into teleconsultation, disease diagnosis, drug discovery, training and education. Tele-consultation is the largest market and is expected to register the fastest growth in the market owing to the increasing need for quality, and fast diagnosis have enhanced the utilisation of teleconsultation applications. By geography, the market is classified into UK, Germany, France, Italy, Spain and others.
Europe Digital Pathology Market Trends:
- Leica Biosystems and KUB Technologies, Inc. are pleased to announce a new global distribution agreement for Kubtec’s specimen imaging systems.
- The digital pathology industry just took another step forward, with the FDA clearance of a whole slide imaging system for review of digital surgical pathology slides.
Europe Digital Pathology Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have a complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried out to understand the market more comprehensively.
Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact on altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary critical players in the Europe Digital Pathology Market are:
- GE Healthcare
- Inspirata Co.
- Ventana Medical Systems, Inc.
- Leica Biosystems
- 3DHistech Ltd
- Hamamatsu Photonics, K.K.
Along with these companies, there were many other companies considered/ cited in the report while analysing the Europe Digital Pathology market. These companies hold substantial share-owning to the nature of the industry whereas the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and stable customer base.
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. The high efficiency of system, analysis and workflow
4.1.2. Application in cancer diagnosis
4.1.3. Ease in transportation and storage
4.1.4. Increasing initiatives by governments and industry players
4.2. Restraints & Challenges
4.2.1. Lack of essential infrastructure in developing countries
4.2.2. Reluctance towards the adoption of digital pathology
4.2.3. Inadequate infrastructure
4.3. Opportunities
4.3.1. Increasing application of digital pathology
4.3.2. Evolving awareness towards pertaining digital pathology
4.3.3. Addition of laboratory and digital pathology systems
4.3.4. Emerging markets to offer lucrative growth opportunities
5. Europe Digital Pathology Market– By Type
5.1. Human digital pathology
5.2. Animal digital pathology
5.3. Others
6. Europe Digital Pathology Market- By Product
6.1. Scanners
6.2. Software
6.3. Communication Systems
6.4. Storage Systems
6.5. Others
7. Europe Digital Pathology Market– By Application
7.1. Teleconsultation
7.2. Disease Diagnosis
7.3. Drug Discovery
7.4. Training and education
7.5. Others
8. Europe Digital Pathology Market-By End User
8.1. Pharmaceutical & Biotechnology Companies
8.2. Hospitals and Reference Laboratories
8.3. Academic & Research Institutes
8.4. Others
9. Europe Digital Pathology Market– By Geography
9.1. Europe
9.1.1. U.K.
9.1.2. Germany
9.1.3. France
9.1.4. Italy
9.1.5. Spain
9.1.6. Russia
9.1.7. Others
10. Europe Digital Pathology Market– Company Profiles
10.1. Leica Biosystems
10.2. Hamamatsu Photonics Inc.
10.3. Olympus Corporation
10.4. Koninklijke Philips N.V
10.5. GE Healthcare
10.6. Inspirata Co.
10.7. Ventana Medical Systems, Inc.
10.8. Leica Biosystems
10.9. 3DHistech Ltd
10.10. Hamamatsu Photonics, K.K.
10.11. Digipath Co.
10.12. Carl Zeiss AG
10.13. Olympus Corporation
10.14. Yokogawa Electronic Corporation
10.15. Quorum Technologies Inc.
11. Europe Digital Pathology Market- Competitive Landscape
11.1. Market Share Analysis
11.2. Strategies Adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
12. Market Insights
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
13. Appendix
13.1. List of tables
13.2. List of figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.
Related Products
Global NGS-based RNA Sequencing Market – Size, Outlook, Trend...
Global Microbiome Sequencing Services Market – Size, Outlook,...
Global Health Insurance Exchange Market – Size, Outlook, Tren...
Global Terahertz And Infrared Spectroscopy Market – Size, Out...